FIELD: medicine.
SUBSTANCE: invention relates to medicine, particularly the treatment of addictions and primary impulse disorders in patients at risk from substances selected from the group consisting of alcohol, nicotine, opioid agonist and cocaine. To this end, the patient is administered a unit dosage form of a pharmaceutical composition that contains a selective phosphodiesterase 7 (PDE7) inhibitor, and an additional therapeutic agent in amounts effective to treat or reduce the likelihood of addiction to alcohol, nicotine, opioid agonist and cocaine. Kit used to treat or reduce the likelihood of addiction includes a first container containing a selective PDE7 inhibitor and a second container containing an additional therapeutic agent.
EFFECT: invention provides prevention and treatment of drug addiction and behavioural dependence with the use of PDE7.
16 cl, 20 dwg, 3 ex
| Title | Year | Author | Number |
|---|---|---|---|
| TREATMENT OF ADDICTION AND IMPULSE-CONTROL DISORDERS USING PDE7 INHIBITORS | 2013 |
|
RU2665134C2 |
| USE OF PDE7 INHIBITORS FOR THE TREATMENT OF MOVEMENT DISORDERS | 2010 |
|
RU2600869C2 |
| MACROCYCLIC HEPATITIS TYPE C VIRUS INHIBITORS | 2006 |
|
RU2419619C2 |
| PYRAZOLPYRIMIDINE COMPOUNDS JAK INHIBITORS AND METHODS | 2009 |
|
RU2539568C2 |
| HEPATITIS C VIRUS MACROCYCLIC INHIBITORS | 2006 |
|
RU2486189C2 |
| MACROCYCLIC INHIBITORS OF HEPATITIS C VIRUS | 2006 |
|
RU2441870C2 |
| PYRAZOLE DERIVATIVES APPLIED AS PROTEIN KINASE INHIBITORS | 2001 |
|
RU2340611C2 |
| THERAPEUTICALLY ACTIVE DERIVATIVES OF OXAZOLINE | 2013 |
|
RU2656209C2 |
| COMBINATION, INCLUDING A) PYRIMIDYLAMINOBENZAMIDE AND B) KINASE Thr315lle INHIBITOR | 2007 |
|
RU2481840C2 |
| NEW DIAMIDES PYRIMIDIN-4,6 OF DICARBOXYLIC ACID FOR SELECTIVE INHIBITION OF COLLAGENASES | 2003 |
|
RU2344129C2 |
